Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000955848 | SCV001102581 | likely benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2024-12-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001531530 | SCV001746718 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | RTEL1: BP4, BP7 |
Breakthrough Genomics, |
RCV001531530 | SCV005210180 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Ambry Genetics | RCV004958325 | SCV005492477 | likely benign | Inborn genetic diseases | 2024-10-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001277132 | SCV001463960 | uncertain significance | Dyskeratosis congenita | 2020-01-24 | no assertion criteria provided | clinical testing |